The Cyprus Association of Research based Companies (KEFEA) Code of Practice, hereinafter called «the Code», covers the promotion of prescription only medicinal products. “Promotion includes every activity undertaken, organised or carried on by a pharmaceutical company or commissioned thereby, promoting the prescription, supplying, sale, administration or consumption of the medicinal product of companies - members of KEFEA. Pharmaceutical companies which are not members of KEFEA but their mother companies or their representatives in Cyprus are members of EFPIA have an obligation to comply with the provisions of this Code. The term «medicinal product», as used in the Code bears the meaning determined in article 1 of Directive 2004/27 on the Community Code relating to medicinal products for human use (Official Journal of the European Communities L 136/30-11-2004) as well as section 3 of the Medicinal Products for Human Use (Control of Quality, Supplies and Price) Law of 2001 as amended or to be amended (Law).
KEFEA is the representative body of International Pharmaceutical Companies and is a member of EFPIA. Is particularly sensitive in supplying to the health professionals objectively correct information for the proper use of medicinal products as it is mandated by Directive 2001/83/EC and which includes the existence of a system of self regulation and correction of practices relating to the promotion of medicinal products.
KEFEA with the introduction and setting up of this Code wants to ensure that the promotion of medicinal products to health professionals is done with a transparent and sincere way without malice in accordance with the Law.